$154.06 Nov 18, 2026 · market cap $20.7B
Alnylam Pharmaceuticals trades at $154. Our two models put it at $73–$105 (base $105): above both.
Buffett $105 · Cash Flow $73 · models run Nov 18, 2026
9 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app